Annual report pursuant to Section 13 and 15(d)

EQUITY (Details 1)

v3.19.3.a.u2
EQUITY (Details 1)
12 Months Ended
Sep. 30, 2019
$ / shares
shares
Options, Outstanding [Roll Forward]  
Outstanding, Ending balance | shares 6,375,966
Exercisable, ending | shares 4,117,187
Options, Outstanding, Weighted Average Exercise Price [Rollforward]  
Granted $ 2.52
Outstanding, Ending balance 2.70
Exercisable, ended $ 1.23